HIV Policy and Advocacy

Advocate D. Rashaan Gilmore explains how white-led HIV organizations in the U.S. engage in movement capture—e.g., the co-opting of Black racial justice efforts—under the guise of ending the HIV epidemic.

Jan. 2, 2020: Cancer treatment among people with HIV in the Obamacare era; chemotherapy, CD4 count, and mortality; cutting meds to cut costs; tailoring interventions on the microepidemic level.

One New York-based provider who works specifically with trans and gender non-conforming patients outlines what needs to change in the health care world to get Black trans women the care they deserve.

Even after a series of reforms in 2015, advocates say U.S. policy still discriminates and furthers HIV stigma. Anthony Santella, Dr.P.H., M.P.H., has a better idea.

Re-entry planning can help prevent opioid overdose and enable people living with HIV to connect with and stay in care.

The attention of this specific U.S. president on HIV is curious. However, while it may be initially disorienting, it makes sense, explains David Wohl, M.D.

Although you may not have known -- or even heard of -- Charles van der Horst, his DNA is woven into the cloth of HIV care and research.

In this op-ed, a group of family physicians and HIV specialists revisit the cruel reality happening at the U.S. border for people living with HIV.

Even in the medical and research communities, stigmatizing language lives on, and it can have negative repercussions in the lives of people with HIV.

Nurses who care for people living with HIV wrestled with stigma around the illness at the Association of Nurses in AIDS Care conference.